Nicole Lou is a Senior Staff Writer for MedPage Today, with a focus on medical reporting. With previous experience at TCTMD, Popular Science, and Audubon Magazine, Nicole covers a wide range of topics in the medical field, including cardiovascular health, pharmaceuticals, and healthcare policy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Nicole Lou's coverage heavily focuses on healthcare and pharmaceuticals, particularly topics related to cardiac health, medical research, treatments, and controversies in the healthcare industry. Her articles often cite data extensively.
She would likely welcome pitches that offer access to new or exclusive data related to developments in cardiac health, medical research breakthroughs or controversies within the healthcare industry. Additionally, she may be interested in expert commentary from professionals with direct experience or involvement in the subjects covered.
Given her focus on citing data extensively, sources who can provide robust and reliable statistics as well as evidence-based insights will be of particular interest to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Nicole
Recent developments of interest in cardiovascular medicine
Trials favor a first new class of pain drug in years
— Question of when to test involves navigating patient privacy, legal, ethical concerns
— Larger pool of TAVR candidates suggested by EARLY TAVR trial results
— Stent-related events plateaued 6 months after DynamX implant For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX
By: Nicole Lou
— Administration at first medical contact at PCI hospital tied to more spontaneous reperfusion
By: Nicole Lou
— Recent developments of interest in cardiovascular medicine A Chinese study suggested that cold weather may make people more susceptible
— Larger CLEAR OASIS 9 trial could not replicate past results Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered randomized trial, researchers found.
By: Nicole Lou
— Evoque device helped outcomes in severe tricuspid regurgitation, with some safety caveats
By: Nicole Lou
— Recent developments of interest in cardiovascular medicine Rates of survival after out-of-hospital cardiac arrest (OHCA) have not fully
(833) 317-6278 
